|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 601 PENNSYLVANIA AVENUE, NW |
Address2 | SUITE 700 |
City | WASHINGTON, DC |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Washington |
State | DC |
Zip Code | 20004 |
Country | USA |
|
5. Senate ID# 89177-12
|
||||||||
|
6. House ID# 366750000
|
TYPE OF REPORT | 8. Year | 2010 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Barbara W. Cosgriff, Sr. Vice President, Public Policy and External Affairs |
Date | 01/20/2011 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Issues related to comprehensive health care reform: Health Information Technology; ARRA Privacy and Security Rules; Generic Biologics; Comparative Effectiveness; Importation of Prescription Drugs; Competitive Bidding; Chronic Care Management; Healthcare Reform; and Healthcare Implementation
H.R. 1 - American Recovery and Reinvestment Act of 2009; Title VIII Department of Labor, Health and Human Services, and Education, and related agencies; Healthcare Research and Quality and Title XIII - Health Information Technology for Economic and Clinical Health Act or the HITECH Act; all sections
H.R. 1321 and S. 391 - Healthy Americans Act; all sections
H.R. 1427 and S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act; all sections
H.R. 1548- Pathway for Biosimilars Act; all sections
H.R. 3200 - America's Affordable Health Choices Act; all sections
H.R. 3596 - Health Insurance Industry Antitrust Enforcement Act of 2009; all sections
H.R. 3962 - Affordable Healthcare for America Act; all sections
Public Law 111-148 - Patient Protection and Affordable Care Act; all sections (formerly H.R. 3590)
H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act; all sections
Public Law 111-152 - Health Care and Education Reconciliation Act of 2010; all sections (formerly H.R. 4872 and S. Con. Res. 13)
H.R. 4489 - The FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act of 2010; all sections
H.R. 5235 - The Medicare Access to Diabetes Supplies Act; all sections
H.R. 3790 - To Amend Title XVIII of the Social Security Act to repeal the Medicare Competitive Acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS); all sections
Public Law 104-191 - Health Insurance Portability and Accountability Act (HIPAA); Title II
H.R. 5440 - Genomics and Personalized Medicine Act of 2010; all sections
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Executive Office of the President (EOP),
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Barbara |
Cosgriff |
|
|
|
Peter |
Harty |
|
N/A |
|
Lillian |
German |
|
|
|
Ryan |
Sadler |
|
|
|
Jennifer |
Romans |
|
Sr. Policy Advisor, Sen. John Kyl |
|
Heather |
Stewart |
|
|
|
Andrea |
Bergman |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Healthcare reform; healthcare regulations; Medicare Part D; proposed antitrust exemptions for certain pharmacies; IVIG payments; Medicare demonstration projects for durable medical equipment; importation of prescription drugs; home infusion; disclosure of PBM information; changes to drug benefits offered under the FEHBP and increasing healthcare value; competitive bidding; proposed revisions to the blood glucose local coverage determination
H.R. 574 and S. 254 - Medicare Home Infusion Therapy Coverage Act of 2009; all sections
H.R. 1204 - Community Pharmacy Fairness Act of 2009; all sections
H.R. 1765 - To Amend Title XVIII of the Social Security Act with respect to payment for the furnishing of intravenous immune globulin (IVIG) in a patient's home for the treatment of primary immune deficiency diseases and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program; all sections
H.R. 5597 - To Establish a Medicare Patient IVIG Access Demonstration Project; all sections
H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009; all sections
H.R. 3962 - Affordable Healthcare for All America Act of 2009; all sections
S. 1796 - America's Healthy Future Act of 2009; sections 1001 - 2221
H.R. 3790 - To amend Title XVIII of the Social Security Act to repeal the Medicare Competitive Acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS); all sections
H.R. 4752 - Medicare Prescription Drug Price Negotiations Act of 2010; all sections
Public Law 111-152 - Healthcare and Education Reconciliation Act of 2010 (formerly H.R. 4872); all sections
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Health & Human Services - Dept of (HHS), Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Barbara |
Cosgriff |
|
|
|
Peter |
Harty |
|
N/A |
|
Lillian |
German |
|
|
|
Ryan |
Sadler |
|
|
|
Jennifer |
Romans |
|
Sr. Policy Advisor, Sen. John Kyl |
|
Andrea |
Bergman |
|
|
|
Heather |
Stewart |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Healthcare reform; antitrust exemptions for independent pharmacists; PBM auditing rules; mail order pharmacy; federal employee health benefits program
H.R. 1204 - Community Pharmacy Fairness Act of 2009; all sections
H.R. 4489 - The FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act of 2010; all sections
H.R. 5234 - PBM Audit Reform and Transparency Act of 2010; all sections
H.R. 4199 - Patient Health and Reinvestment Act of 2009; all sections
H.R. 1 - American Recovery and Reinvestment Act of 2009; Title XIII - Health Information Technology for Economic and Clinical Health Act or the HITECH Act; all sections
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Health & Human Services - Dept of (HHS), Office of Personnel Management (OPM),
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Barbara |
Cosgriff |
|
|
|
Lillian |
German |
|
|
|
Andrea |
Bergman |
|
|
|
Heather |
Stewart |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code POS
16. Specific lobbying issues
issues related to proposals to limit mail delivery by the U.S. postal service
H.R. 5746 - The United States Postal Service's CSR Obligation Modification Act of 2010; all sections
H.R. 5919 - To Grant the Postmaster General the Authority to Implement up to 12 Non-Mail Delivery Days Each Fiscal Year for the United States Postal Service
S. 3831 - The Postal Operations Sustainment and Transformation Act or the POST Act of 2010; all sections
S. 4000 - The U.S. Postal Service Improvements Act of 2010; all sections
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Postal Regulatory Commission, Postal Rate Commission, U.S. Postal Service (USPS),
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Barbara |
Cosgriff |
|
|
|
Lillian |
German |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
Accredo Health Group, Inc. |
|
|
||||||||||||
Liberty Medical Supply, Inc. |
|
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |